Filing Details
- Accession Number:
- 0001482981-23-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-03 18:21:34
- Reporting Period:
- 2023-11-01
- Accepted Time:
- 2023-11-03 18:21:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1482981 | Vita Coco Company Inc. | COCO | Beverages (2080) | 113713156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1886142 | Jonathan Burth | 250 Park Ave South Seventh Floor New York NY 10003 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-01 | 10,469 | $28.05 | 188,588 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-02 | 12,071 | $30.04 | 176,517 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-11-02 | 11,600 | $10.18 | 188,117 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-02 | 11,600 | $30.04 | 176,517 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-11-02 | 11,600 | $0.00 | 11,600 | $10.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 137,225 | 2029-12-16 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | $10.18 | 2030-02-10 | 204,750 | 204,750 | Direct | |
| Common Stock | Non-Qualified Stock Option (right to buy) | $10.18 | 2031-01-11 | 34,125 | 34,125 | Direct | |
| Common Stock | Non-Qualified Stock Option (right to buy) | $15.00 | 2031-10-21 | 58,043 | 58,043 | Direct | |
| Common Stock | Non-Qualified Stock Option (right to buy) | $15.36 | 2032-08-15 | 42,980 | 42,980 | Direct | |
| Common Stock | Non-Qualified Stock Option (right to buy) | $16.91 | 2033-03-10 | 14,205 | 14,205 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2030-02-10 | 204,750 | 204,750 | Direct |
| 2031-01-11 | 34,125 | 34,125 | Direct |
| 2031-10-21 | 58,043 | 58,043 | Direct |
| 2032-08-15 | 42,980 | 42,980 | Direct |
| 2033-03-10 | 14,205 | 14,205 | Direct |
Footnotes
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Due to a clerical error on the Reporting Person's Form 4 filing on December 1, 2022, the number of shares beneficially owned was inadvertently understated by 11,667 shares. The amounts in Column 5 list the correct number of shares beneficially owned.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The stock option is fully vested and currently exercisable.
- The stock option is fully vested and currently exercisable with respect to 102,375 underlying shares. The remainder will vest on February 10, 2024.
- The stock option vests in two equal installments on January 11, 2023 and January 11, 2025.
- The stock option vests in four equal annual installments beginning on November 27, 2022.
- The stock option vests in three equal annual installments beginning on August 15, 2025.
- The stock options vest in four annual equal installments beginning on March 10, 2024.
Billionaire Hedge Funds
